Randomized, Double-blind, Placebo-controlled Study to Assess Fatigue in Patients With ACD Due to RA Receiving PROCRIT

Stopped This study was terminated due to slow enrollment, despite protocol amendments to change the entrance criteria.

Conditions

• Anemia
• Rheumatoid Arthritis

Interventions

• DRUG: Epoetin alfa

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Collaborators

• [object Object]